Compound Evidence File
#EC-2026-0611
Nitroethane CAS 79-24-3
Filed under Raw Materials. The bureau holds 144 laboratory returns for this compound from 45 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
45 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 11 Mar 2026 | 6 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 20 Jan 2026 | 12 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 9.9 | 10.0 | 12 Mar 2026 | 17 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 7 Apr 2026 | 4 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 9.9 | 10.0 | 5 Mar 2026 | 14 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 17 Apr 2026 | 3 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Feb 2026 | 3 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 3 Jan 2026 | 12 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 9.9 | 10.0 | 15 May 2026 | 25 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 10.0 | 10.0 | 16 Feb 2026 | 26 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 1 Mar 2026 | 23 Apr 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Nov 2025 | 17 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 17 Apr 2026 | 8 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 1 May 2026 | 1 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 27 Feb 2026 | 16 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Apr 2026 | 22 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 27 Mar 2026 | 25 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 10.0 | 19 May 2026 | 3 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 9.9 | 23 May 2026 | 13 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 27 May 2026 | 17 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 27 May 2026 | 17 Aug 2026 |
| Elite Research USACASE #VI-2026-0267 | X | 1 | 8.5 | 8.5 | 8.5 | 2 Apr 2025 | 2 Apr 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.4 | 6.8 | 9.1 | 21 May 2026 | 21 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.3 | 6.7 | 10.0 | 23 May 2026 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.2 | 6.9 | 9.4 | 23 May 2026 | 23 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.0 | 6.6 | 9.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.0 | 6.8 | 9.2 | 25 May 2026 | 25 May 2026 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 7.9 | 7.9 | 7.9 | 28 Mar 2025 | 28 Mar 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 7.8 | 7.8 | 7.8 | 14 Jan 2025 | 14 Jan 2025 |
| Alpha-GenCASE #VI-2026-0905 | X | 1 | 7.4 | 7.4 | 7.4 | 11 Jun 2025 | 11 Jun 2025 |
| Peptide SciencesCASE #VI-2026-0867 | X | 6 | 7.1 | 5.3 | 8.7 | 25 Apr 2025 | 24 May 2026 |
| Platinum CryoCASE #VI-2026-0406 | X | 2 | 7.0 | 6.5 | 7.4 | 16 Mar 2025 | 24 May 2026 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 6.9 | 5.6 | 8.2 | 20 Jun 2025 | 19 Jan 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 4 | 6.8 | 4.6 | 9.4 | 25 Apr 2025 | 21 May 2026 |
| Planet PeptideCASE #VI-2026-0092 | X | 4 | 6.8 | 3.8 | 9.4 | 27 Feb 2025 | 25 May 2026 |
| BeiBangAnCASE #VI-2026-0899 | X | 1 | 6.6 | 6.6 | 6.6 | 8 Jul 2025 | 8 Jul 2025 |
| LSPLCASE #VI-2026-0523 | X | 1 | 5.7 | 5.7 | 5.7 | 7 May 2025 | 7 May 2025 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 5.4 | 5.4 | 5.4 | 20 Jun 2025 | 20 Jun 2025 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 5.0 | 5.0 | 5.0 | 28 Mar 2025 | 28 Mar 2025 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 4.4 | 4.4 | 4.4 | 25 Apr 2025 | 25 Apr 2025 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 4.3 | 4.3 | 4.3 | 13 Feb 2025 | 13 Feb 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 3.3 | 3.3 | 3.3 | 13 Feb 2025 | 13 Feb 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Jul 2025 | 2 Jul 2025 |
Open any subject to view the batch-level evidence for Nitroethane CAS 79-24-3 alone.